Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 505,132 | 445,222 | 361,626 | 315,269 | 264,714 |
| Operating Income | -505,132 | -445,222 | -361,626 | -315,269 | -264,714 |
| Interest Expense | 23,781 | 12,197 | 11,936 | 11,428 | 867 |
| Other Income | -115,458 | 3,603 | 8,670 | 21,491 | 17,794 |
| Pre-tax Income | -644,371 | -453,816 | -364,892 | -305,206 | -247,787 |
| Net Income Continuous | -644,371 | -453,816 | -364,892 | -305,206 | -247,787 |
| Net Income | $-644,371 | $-453,816 | $-364,892 | $-305,206 | $-247,787 |
| EPS Basic Total Ops | -3.06 | -2.29 | -1.90 | -1.61 | -1.31 |
| EPS Basic Continuous Ops | -3.06 | -2.29 | -1.89 | -1.61 | -1.31 |
| EPS Diluted Total Ops | -3.06 | -2.29 | -1.90 | -1.61 | -1.31 |
| EPS Diluted Continuous Ops | -3.06 | -2.29 | -1.89 | -1.61 | -1.31 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.29 | -1.86 | -1.61 | -1.31 |
| EBITDA(a) | $-504,965 | $-443,910 | $-361,478 | $-316,648 | $-268,655 |